Literature DB >> 17434151

Pretreatment with volatile anesthetics, but not with the nonimmobilizer 1,2-dichlorohexafluorocyclobutane, reduced cell injury in rat cerebellar slices after an in vitro simulated ischemia.

Chengbin Wang1, Jeong Jin Lee, Hae-Hyuk Jung, Zhiyi Zuo.   

Abstract

A prior exposure to the volatile anesthetic isoflurane has been shown to induce neuroprotection in rats. This phenomenon is called preconditioning. We designed this study to determine whether the potency of volatile anesthetics in inducing neuropreconditioning is related to their potency to induce anesthesia. Cerebellar slices of adult male Sprague-Dawley rats were exposed to various concentrations of isoflurane, halothane, sevoflurane, desflurane or the nonimmobilizer 1,2-dichlorohexafluorocyclobutane for 15 min, followed by a 15-min drug-free period, and then were subjected to oxygen-glucose deprivation for 10 min at 37 degrees C. After a 5-h recovery at 37 degrees C, brain slices were used for quantification of cell injury by spectrophotometric measurement of formazan produced from 2,3,5-triphenyltetrazolium chloride. All four volatile anesthetics induced a concentration-dependent preconditioning effect. The EC50 for this effect induced by isoflurane, halothane, sevoflurane or desflurane was 221, 173, 184 and 929 microM, respectively. This EC50 was linearly correlated with the aqueous concentration of one minimum alveolar concentration. The volatile anesthetic preconditioning-induced neuroprotection was abolished by DL-threo-beta-hydroxyaspartic acid, DL-threo-beta-benzyloxyaspartate or dihydrokainate, glutamate transporter inhibitors. The volatile nonimmobilizer 1,2-dichlorohexafluorocyclobutane at any concentrations tested in the study did not induce a significant preconditioning effect. Isoflurane preconditioning did not change the oxygen-glucose deprivation-induced glutamate accumulation. These results suggest that the preconditioning-induced neuroprotection by volatile anesthetics is not agent-specific. Mechanisms that are involved in inducing anesthesia may contribute to the induction of preconditioning effect by volatile anesthetics. Modification of glutamate transporter activity may be one of such mechanisms to induce these protective effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434151      PMCID: PMC1950153          DOI: 10.1016/j.brainres.2007.03.030

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  47 in total

1.  Glutamate release in severe brain ischaemia is mainly by reversed uptake.

Authors:  D J Rossi; T Oshima; D Attwell
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

2.  Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor.

Authors:  Joel G R Weaver; Agathe Tarze; Tia C Moffat; Morgane Lebras; Aurelien Deniaud; Catherine Brenner; Gary D Bren; Mario Y Morin; Barbara N Phenix; Li Dong; Susan X Jiang; Valerie L Sim; Bogdan Zurakowski; Jessica Lallier; Heather Hardin; Peter Wettstein; Rolf P G van Heeswijk; Andre Douen; Romano T Kroemer; Sheng T Hou; Steffany A L Bennett; David H Lynch; Guido Kroemer; Andrew D Badley
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

3.  Inhibition of glutamate transporters increases the minimum alveolar concentration for isoflurane in rats.

Authors:  S Cechova; Z Zuo
Journal:  Br J Anaesth       Date:  2006-06-21       Impact factor: 9.166

4.  Sevoflurane-induced preconditioning protects against cerebral ischemic neuronal damage in rats.

Authors:  Ralphiel S Payne; Ozan Akca; Norbert Roewer; Avital Schurr; Franz Kehl
Journal:  Brain Res       Date:  2005-02-09       Impact factor: 3.252

5.  Births and deaths: preliminary data for 1998.

Authors:  J A Martin; B L Smith; T J Mathews; S J Ventura
Journal:  Natl Vital Stat Rep       Date:  1999-10-05

Review 6.  Ischemic cell death in brain neurons.

Authors:  P Lipton
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

7.  Critical role of serine 465 in isoflurane-induced increase of cell-surface redistribution and activity of glutamate transporter type 3.

Authors:  Yueming Huang; Xiaorong Feng; Julianne J Sando; Zhiyi Zuo
Journal:  J Biol Chem       Date:  2006-10-24       Impact factor: 5.157

Review 8.  Ischemic preconditioning in humans: models, mediators, and clinical relevance.

Authors:  F Tomai; F Crea; L Chiariello; P A Gioffrè
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

9.  Spectrophotometric measurement of experimental brain injury.

Authors:  E Preston; J Webster
Journal:  J Neurosci Methods       Date:  2000-01-15       Impact factor: 2.390

10.  Isoflurane induces a protein kinase C alpha-dependent increase in cell-surface protein level and activity of glutamate transporter type 3.

Authors:  Yueming Huang; Zhiyi Zuo
Journal:  Mol Pharmacol       Date:  2005-02-11       Impact factor: 4.436

View more
  19 in total

1.  Myocardial ischemia, reperfusion, and infarction in chronically instrumented, intact, conscious, and unrestrained mice.

Authors:  Heidi L Lujan; Hussein Janbaih; Han-Zhong Feng; Jian-Ping Jin; Stephen E DiCarlo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-04-25       Impact factor: 3.619

2.  Sevoflurane-induced delayed neuroprotection involves mitoK(ATP) channel opening and PKC ε activation.

Authors:  Zhi Ye; Yue-Ming Huang; E Wang; Zhi-Yi Zuo; Qu-Lian Guo
Journal:  Mol Biol Rep       Date:  2012-03-04       Impact factor: 2.316

3.  High doses of ketamine-xylazine anesthesia reduce cardiac ischemia-reperfusion injury in guinea pigs.

Authors:  Ruben C Sloan; Matthew Rosenbaum; Dorcas O'Rourke; Karen Oppelt; Chad R Frasier; Corinne A Waston; Amanda G Allan; David A Brown
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-05       Impact factor: 1.232

4.  Electroacupuncture preconditioning-induced neuroprotection may be mediated by glutamate transporter type 2.

Authors:  Xiaoling Zhu; Jinbo Yin; Liaoliao Li; Lei Ma; Hongying Tan; Jiao Deng; Shaoyang Chen; Zhiyi Zuo
Journal:  Neurochem Int       Date:  2013-07-04       Impact factor: 3.921

Review 5.  The importance of the excitatory amino acid transporter 3 (EAAT3).

Authors:  Walden E Bjørn-Yoshimoto; Suzanne M Underhill
Journal:  Neurochem Int       Date:  2016-05-24       Impact factor: 3.921

6.  Glutamate transporter type 3 mediates isoflurane preconditioning-induced acute phase of neuroprotection in mice.

Authors:  Liaoliao Li; Jiao Deng; Zhiyi Zuo
Journal:  Brain Res Bull       Date:  2013-07-01       Impact factor: 4.077

7.  Isoflurane preconditioning reduces mouse microglial activation and injury induced by lipopolysaccharide and interferon-gamma.

Authors:  X Xu; J A Kim; Z Zuo
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

8.  Inability of volatile anesthetics to inhibit oxygen-glucose deprivation-induced glutamate release via glutamate transporters and anion channels in rat corticostriatal slices.

Authors:  Hae-Hyuk Jung; Jeong Jin Lee; Jacqueline M Washington; Zhiyi Zuo
Journal:  Brain Res       Date:  2008-06-25       Impact factor: 3.252

9.  Postconditioning with isoflurane reduced ischemia-induced brain injury in rats.

Authors:  Jeong Jin Lee; Liaoliao Li; Hae-Hyuk Jung; Zhiyi Zuo
Journal:  Anesthesiology       Date:  2008-06       Impact factor: 7.892

10.  Isoflurane preconditioning improves short-term and long-term neurological outcome after focal brain ischemia in adult rats.

Authors:  L Li; Z Zuo
Journal:  Neuroscience       Date:  2009-08-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.